These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Systemic, noncerebral, arterial embolism in 21,105 patients with atrial fibrillation randomized to edoxaban or warfarin: results from the Effective Anticoagulation With Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis in Myocardial Infarction Study 48 trial. Geller BJ; Giugliano RP; Braunwald E; Murphy SA; Hanyok JJ; Jin J; Mercuri M; Antman EM; Ruff CT Am Heart J; 2015 Oct; 170(4):669-74. PubMed ID: 26386790 [TBL] [Abstract][Full Text] [Related]
4. Anticoagulation Therapy and NOACs in Heart Failure. Thomas I; EncisoSilva J; Schlueter M; Greenberg B Handb Exp Pharmacol; 2017; 243():515-535. PubMed ID: 28233177 [TBL] [Abstract][Full Text] [Related]
6. Novel Anticoagulants in Atrial Fibrillation: A Primer for the Primary Physician. Mookadam M; Shamoun FE; Mookadam F J Am Board Fam Med; 2015; 28(4):510-22. PubMed ID: 26152444 [TBL] [Abstract][Full Text] [Related]
7. Novel oral anticoagulants for stroke prevention in atrial fibrillation: focus on apixaban. Potpara TS; Polovina MM; Licina MM; Stojanovic RM; Prostran MS; Lip GY Adv Ther; 2012 Jun; 29(6):491-507. PubMed ID: 22684583 [TBL] [Abstract][Full Text] [Related]
8. A meta-analysis of phase III randomized controlled trials with novel oral anticoagulants in atrial fibrillation: comparisons between direct thrombin inhibitors vs. factor Xa inhibitors and different dosing regimens. Providência R; Grove EL; Husted S; Barra S; Boveda S; Morais J Thromb Res; 2014 Dec; 134(6):1253-64. PubMed ID: 25457584 [TBL] [Abstract][Full Text] [Related]
9. Rivaroxaban in the Prevention of Stroke and Systemic Embolism in Patients with Non-Valvular Atrial Fibrillation: Clinical Implications of the ROCKET AF Trial and Its Subanalyses. Spencer RJ; Amerena JV Am J Cardiovasc Drugs; 2015 Dec; 15(6):395-401. PubMed ID: 26062914 [TBL] [Abstract][Full Text] [Related]
10. [Anticoagulation for patients with non-valvular atrial fibrillation]. Mizoguchi T; Yasaka M Nihon Rinsho; 2016 Apr; 74(4):627-33. PubMed ID: 27333751 [TBL] [Abstract][Full Text] [Related]
11. Stroke prevention in patients with atrial fibrillation in France: comparative cost-effectiveness of new oral anticoagulants (apixaban, dabigatran, and rivaroxaban), warfarin, and aspirin. Lanitis T; Cotté FE; Gaudin AF; Kachaner I; Kongnakorn T; Durand-Zaleski I J Med Econ; 2014 Aug; 17(8):587-98. PubMed ID: 24831811 [TBL] [Abstract][Full Text] [Related]
12. Comparative effectiveness of warfarin and new oral anticoagulants for the management of atrial fibrillation and venous thromboembolism: a systematic review. Adam SS; McDuffie JR; Ortel TL; Williams JW Ann Intern Med; 2012 Dec; 157(11):796-807. PubMed ID: 22928173 [TBL] [Abstract][Full Text] [Related]